| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $437,178 | 2 | 100 |
| Herr Amy E. | director | 0 | $0 | 2 | $437,178 | $-437,178 |
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue …
Over the last 12 months, insiders at Bio-Techne Corporation have bought $0 and sold $437,178 worth of Bio-Techne Corporation stock.
On average, over the past 5 years, insiders at Bio-Techne Corporation have bought $105,765 and sold $6.1M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 300 shares for transaction amount of $105,765 was made by BAUMGARTNER ROBERT V () on 2022‑05‑10.
| 2026-05-08 | Sale | Herr Amy E. | director | 6,636 0.0042% | $48.28 | $320,386 | +49.47% | |
| 2026-02-17 | Sale | Herr Amy E. | director | 1,976 0.0013% | $59.10 | $116,791 | +21.05% | |
| 2025-08-25 | Sale | BAUMGARTNER ROBERT V | director | 17,040 0.0107% | $56.21 | $957,818 | +4.29% | |
| 2025-08-25 | Sale | Nusse Roeland | director | 17,040 0.0107% | $56.36 | $960,388 | +4.29% | |
| 2025-06-09 | Sale | Herr Amy E. | director | 1,280 0.0008% | $49.77 | $63,705 | +11.81% | |
| 2025-02-14 | Sale | Herr Amy E. | director | 1,860 0.0012% | $65.96 | $122,691 | -12.41% | |
| 2025-01-27 | Sale | Kelderman Kim | Chief Executive Officer | 13,392 0.0085% | $77.29 | $1.04M | -24.29% | |
| 2024-08-08 | Sale | BAUMGARTNER ROBERT V | director | 16,000 0.0099% | $72.10 | $1.15M | -7.79% | |
| 2024-05-14 | Sale | HIGGINS JOHN L | director | 4,000 0.0025% | $83.84 | $335,377 | -12.88% | |
| 2024-03-07 | Sale | Nusse Roeland | director | 10,400 0.0066% | $76.98 | $800,627 | -3.96% | |
| 2023-08-30 | Sale | Nusse Roeland | director | 8,939 0.0057% | $80.32 | $717,959 | -10.38% | |
| 2023-07-21 | Sale | Kummeth Charles R. | Chief Executive Officer | 80,000 0.0503% | $88.36 | $7.07M | -19.34% | |
| 2023-06-07 | Sale | Kummeth Charles R. | Chief Executive Officer | 322 0.0002% | $83.00 | $26,726 | -11.75% | |
| 2022-12-08 | Sale | Furlow Brenda S. | SVP - GENERAL COUNSEL | 7,450 0.0048% | $82.12 | $611,810 | -4.24% | |
| 2022-08-10 | Sale | HIGGINS JOHN L | 100 0.0003% | $374.89 | $37,490 | -14.56% | ||
| 2022-06-07 | Sale | Kummeth Charles R. | CHIEF EXECUTIVE OFFICER | 5,104 0.013% | $365.00 | $1.86M | -10.27% | |
| 2022-06-07 | Sale | HIGGINS JOHN L | 1,000 0.0025% | $364.31 | $364,310 | -10.27% | ||
| 2022-05-10 | BAUMGARTNER ROBERT V | 300 0.0008% | $352.55 | $105,765 | -6.24% | |||
| 2021-11-19 | Sale | Kelderman Kim | Pres. Diagnostics & Genom | 500 0.0013% | $505.38 | $252,689 | -25.89% | |
| 2021-11-12 | Sale | Eansor Norman David | President-Protein Sciences | 27,159 0.069% | $504.00 | $13.69M | -25.51% |
| Kummeth Charles R. | Chief Executive Officer | 1258766 0.8015% | $91.46M | 1 | 21 | +18.32% |
| OCONNELL HOWARD V | director | 70000 0.0446% | $5.09M | 1 | 15 | +32.96% |
| BAUMGARTNER ROBERT V | director | 44863 0.0286% | $3.26M | 6 | 16 | +12.18% |
$961,890,236 | 276 | 22.46% | $23.97B | |
$159,914,414 | 243 | 18.52% | $8.86B | |
$273,531,368 | 93 | 38.24% | $9.16B | |
$2,765,836 | 72 | 20.00% | $10.77B | |
$108,876,545 | 67 | 72.81% | $14.6B |
| Increased Positions | 299 | +45.58% | 24M | +14.36% |
| Decreased Positions | 289 | -44.05% | 17M | -10.42% |
| New Positions | 85 | New | 7M | New |
| Sold Out Positions | 73 | Sold Out | 5M | Sold Out |
| Total Postitions | 666 | +1.52% | 172M | +3.94% |
| Vanguard Group Inc | $1.07M | 11.5% | 17.93M | -505,949 | -2.74% | 2025-09-30 |
| Blackrock, Inc. | $709,064.00 | 7.62% | 11.89M | -284,134 | -2.33% | 2025-09-30 |
| Morgan Stanley | $431,739.00 | 4.64% | 7.24M | +658,935 | +10.02% | 2025-09-30 |
| State Street Corp | $343,190.00 | 3.69% | 5.75M | -105,190 | -1.79% | 2025-09-30 |
| Wellington Management Group Llp | $305,118.00 | 3.28% | 5.12M | +4M | +349.84% | 2025-09-30 |
| Geode Capital Management, Llc | $293,906.00 | 3.16% | 4.93M | +864,669 | +21.28% | 2025-09-30 |
| Invesco Ltd. | $235,381.00 | 2.53% | 3.95M | +283,303 | +7.74% | 2025-09-30 |
| Price T Rowe Associates Inc /Md/ | $199,836.00 | 2.15% | 3.35M | -5M | -62.14% | 2025-09-30 |
| Neuberger Berman Group Llc | $197,269.00 | 2.12% | 3.31M | +807,147 | +32.29% | 2025-09-30 |
| Maverick Capital Ltd | $179,705.00 | 1.93% | 3.01M | +3M | New | 2025-09-30 |